Dr. deVeber helped develop a method using amniocentesis and intrauterine transfusion to treat Rh haemolytic disease, which was a leading cause of fetal and newborn death. He also administered the first dose of Rh immune globulin in Canada. Due to these pioneering efforts, the disease is no longer a major health concern.